| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/11/2026 | ±4.0% | -0.3% | over-priced |
| 05/12/2026 | ±6.2% | +0.3% | over-priced |
| 11/04/2025 | ±3.8% | -1.4% | over-priced |
| 08/05/2025 | ±3.8% | +0.4% | over-priced |
| 05/06/2025 | ±3.3% | -2.6% | over-priced |
| 11/06/2024 | ±4.3% | -0.9% | over-priced |
| 08/06/2024 | ±4.0% | -0.1% | over-priced |
| 05/07/2024 | ±2.6% | +0.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2027 | $0.47 | $730M | $52M |
| Q4 FY2026 | $0.36 | $711M | $41M |
| Q1 FY2027 | — | $0 | $0 |
| Q4 FY2025 | $0.86 | $772M | $98M |
Revvity, Inc. (RVTY) reports in 83 days, with the next report estimated for 12/04/2026. Across the last 8 reports, options priced an average ±4.0% earnings move while the stock actually moved 0.8% on average — the market has systematically over-priced RVTY's earnings risk. Fundamentals into the print: EPS up 17.5% year-over-year, revenue up 4.4%. QuantLogix's live 5-factor engine currently reads RVTY as a buy at 62/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →